conducted a study indicating that MSCs from MM patients increase the expression of CXCL12, a chemokine essential for the homing of myeloma cells to the bone marrow, which contributes to the acceleration of disease progression. The gene discussed is CXCL12; the disease is plasma cell myeloma.